Income Tax Expense (Benefit) in USD of Iterum Therapeutics plc from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Iterum Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and change rate from 2016 to Q3 2025.
  • Iterum Therapeutics plc Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $132K, a 2.94% decline year-over-year.
  • Iterum Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $276K, a 22.7% decline year-over-year.
  • Iterum Therapeutics plc annual Income Tax Expense (Benefit) for 2024 was $240K, a 60.8% decline from 2023.
  • Iterum Therapeutics plc annual Income Tax Expense (Benefit) for 2023 was $613K, a 104% increase from 2022.
  • Iterum Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was $301K, a 57.3% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Iterum Therapeutics plc Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $276K $132K -$4K -2.94% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $280K $59K +$28K +90.3% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $252K $60K +$12K +25% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $240K $25K -$117K -82.4% 01 Oct 2024 31 Dec 2024 10-K 07 Feb 2025
Q3 2024 $357K $136K -$25K -15.5% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 $382K $31K -$156K -83.4% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025
Q1 2024 $538K $48K -$75K -61% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 $613K $142K +$41K +40.6% 01 Oct 2023 31 Dec 2023 10-K 07 Feb 2025
Q3 2023 $572K $161K +$731K 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$159K $187K -$156K -45.5% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$3K $123K -$304K -71.2% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 $301K $101K -$70K -40.9% 01 Oct 2022 31 Dec 2022 10-K 07 Feb 2025
Q3 2022 $371K -$570K -$922K -262% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $1.29M $343K +$221K +181% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 $1.07M $427K +$367K +612% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 $705K $171K +$147K +613% 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2024
Q3 2021 $558K $352K -$68K -16.2% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $626K $122K -$56K -31.5% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 $682K $60K -$61K -50.4% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q4 2020 $743K $24K -$25K -51% 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2023
Q3 2020 $768K $420K +$316K +304% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $452K $178K +$21K +13.4% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 $431K $121K -$13K -9.7% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 $444K $49K -$157K -76.2% 01 Oct 2019 31 Dec 2019 10-K 28 Mar 2022
Q3 2019 $601K $104K -$5K -4.59% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $606K $157K +$89K +131% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $517K $134K +$45K +50.6% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 $472K $206K 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2021
Q3 2018 $109K +$21K +23.9% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $68K -$10K -12.8% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $89K 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019
Q3 2017 $88K 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $78K 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018

Iterum Therapeutics plc Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $240K -$373K -60.8% 01 Jan 2024 31 Dec 2024 10-K 07 Feb 2025
2023 $613K +$312K +104% 01 Jan 2023 31 Dec 2023 10-K 07 Feb 2025
2022 $301K -$404K -57.3% 01 Jan 2022 31 Dec 2022 10-K 07 Feb 2025
2021 $705K -$38K -5.11% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2024
2020 $743K +$299K +67.3% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2023
2019 $444K -$28K -5.93% 01 Jan 2019 31 Dec 2019 10-K 28 Mar 2022
2018 $472K +$28K +6.31% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021
2017 $444K +$331K +293% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020
2016 $113K 01 Jan 2016 31 Dec 2016 10-K 25 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.